Drug application
THYROLAR-0.25 (LIOTRIX (T4, T3))
Drugs@FDA NDA 016807 · ALLERGAN
Key facts
| Drug name | THYROLAR-0.25 |
|---|---|
| Active ingredients | LIOTRIX (T4, T3) |
| Application type | NDA |
| Application number | 016807 |
| Company | ALLERGAN |
| Dosage forms | TABLET, ORAL |
| Strength | 0.0125MG;0.0031MG |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission class | Type 5 - New Formulation or New Manufacturer |
| Latest submission status date | Nov 21, 1969 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: